Efficacy and Safety of Recombinant Human Prourokinase for the Treatment of Acute Ischemic Stroke Within 4.5 Hours of Stroke Onset
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Efficacy and Safety of Recombinant Human Prourokinase in the Treatment of Acute Ischemic Stroke Within 4.5 Hours of Stroke Onset: A Phase 3 Randomized Clinical Trial
JAMA Netw Open 2023 Jul 25;6(7)e2325415, H Song, Y Wang, Q Ma, W Feng, R Liu, X Lv, L Huang, Y Li, Y Yang, D Geng, J Zhu, Y Wei, H Chen, R Zhu, Q Zhai, J Guo, B Liu, S Zhao, Y WangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.